Motus GI
Motus GI Holdings, Inc., a medical technology company, offers endoscopy solutions in the United States and Israel that improve clinical outcomes and cost-efficiency in the diagnosis and management of gastrointestinal conditions.
The Pure-Vu system, a medical device used to clean a poorly prepared colon during a colonoscopy procedure, is its flagship product. The headquarters of the company are in Fort Lauderdale, Florida.
- NASDAQ: MOTS
- Stock Price: $0.97 (-$0.03)
- PE Ratio: -1.36
- Market Cap: $32.24 million
- Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target: $2.40 (148.6% Upside)
Market Cap: 19.794M
